AntlerA Therapeutics


AntlerA Therapies is a regenerative medicine startup that is working on protein therapeutics that modulate developmental signaling pathways while also mobilizing tissue stem cell activity to enable endogenous tissue repair. They generated powerful antibody-like molecules (ANTs) that activate certain Frizzed receptor complexes using their unique protein engineering platform.

Industries

biotechnology
medical
therapeutics

Nr. of Employees

small (1-50)

AntlerA Therapeutics

Toronto, Ontario, Canada, North America


Patents

Method of screening for compounds that inhibit proliferation of pancreatic cancer cells having a loss-of-function mutation in the RNF43 gene

US-12600785-B2

View Details

Antibodies that bind to LRP6 proteins and methods of use

US-12583919-B2

View Details

Frizzled5 protein-binding agents

US-10919968-B2

View Details

Antibodies against Frizzled receptor

US-10689442-B2

View Details

Antibodies against frizzled receptor

US-10077304-B2

View Details

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.